ANDAINJECTIONINJECTABLE
Approved
Jun 1988
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug Shortage Active
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is currently in shortage. Reason: Available. This may impact manufacturing, supply chain, and quality hiring at the manufacturer.
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (lidocaine hydrochloride and epinephrine) by Pfizer is adrenergic alpha-agonists [moa]. First approved in 1988.
Drug data last refreshed 1w ago
Mechanism of Action
Adrenergic alpha-Agonists
Pharmacologic Class:
alpha-Adrenergic Agonist
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Pfizer
NEW YORK, NY
Worked on LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.